Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform

Off-patent medicines ready to drive pharma policy reform for… 15 June 2023 The EU has initiated a major overhaul of EU pharma…
Access to medicines and security of supply should be central… 13 June 2023 Generic and biosimilar medicines significantly lower healthcare treatment costs and…
Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…
EU pharmaceutical legislation must support a competitive… 20 December 2021 Open